On the stock market since 2020, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 39% below its peak. The market has trimmed its expectations for the company.
Sales run at $233K a year. A small number, but proof the product has real buyers.
A loss of $34.0M against $233K in annual sales.
On our five-subject report card, CFACU sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CFACU is a high-risk stock — not yet profitable, and its future rides on its product catching on.